ENTITY

BrainStorm Cell Therapeutics I (BCLI US)

4
Analysis
Health CareUnited States
BrainStorm Cell Therapeutics Inc. is a biotechnology company developing autologous adult stem cell therapies for neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS) and Parkinson's disease (PD).
more
Refresh
Exchange Announcement20 Jul 2024 04:05
Exchange Announcement28 Jun 2024 22:49
Exchange Announcement28 Jun 2024 19:30
Exchange Announcement27 Jun 2024 21:00
Exchange Announcement27 Jun 2024 04:01
x